...

Bracco Imaging and NYU Langone Health to Forge Partnership for Medical Imaging Innovation

Bracco Imaging and NYU Langone Health to Forge Partnership

Bracco Imaging and NYU Langone Health recently announced a new strategic alliance agreement. This collaboration focuses on advancing medical imaging innovation through joint research. Both organizations intend to develop and test new diagnostic tools. The alliance will utilize its mutual strengths in clinical research and imaging technology.

The contract establishes a structured system for research and development activities. The initiatives will investigate the application of modern contrast agents. They will also investigate new imaging modalities to improve diagnostic accuracy. By working together, the entities seek to accelerate the transition from lab research to clinical practice.

“The agreement reflects a shared commitment between the Bracco Group and NYU Langone Health to advance research and clinical innovation in medical imaging. NYU Langone Health is among the world’s most respected leaders in radiology, with a proven history in translational research and an exceptional ability to combine clinical practice, advanced technologies, and academic expertise. By combining our respective strengths, we aim to further enhance diagnostic performance, streamline clinical workflows, and ultimately generate meaningful impact for patients and healthcare systems,” said Fulvio Renoldi Bracco, Vice Chairman and CEO of Bracco Imaging.

Advancing Diagnostics Through Joint Research Initiatives

The alliance aims to refine imaging protocols across various patient conditions. Experts from both organizations will participate in clinical studies and data analysis. This joint effort targets improvements in image quality and patient safety. Furthermore, the partnership facilitates knowledge exchange between industry developers and academic clinicians.

“Diagnostic imaging is advancing at a remarkable pace, and strategic collaborations are essential to progress. We are excited to build on NYU Langone Health’s legacy of advances and to work with the Bracco Group toward breakthroughs in modalities central to precision medicine in terms of superior diagnostic accuracy and enhanced clinical decision-making,” noted Michael P. Recht, M.D., the Louis Marx Professor of Radiology and chair of the Department of Radiology at NYU Grossman School of Medicine.

Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: PRNewswire.com